Table 1.
Baseline characteristics of patients with adrenal cortical carcinoma (n = 37) and benign adrenal adenoma (n = 8).
| Variable | ACC (n = 37) | Benign (n = 8) |
|---|---|---|
| Age | 48.5 ± 12.9 | 51.9 ± 10.5 |
| Male | 15 (40.5) | 4 (50.0) |
| Initial Stage (ENSAT) | ||
| I | 2 (5.4) | - |
| II | 7 (18.9) | - |
| III | 17 (45.9) | - |
| IV | 11 (29.7) | - |
| Death | 19 (51.4) | - |
| Follow-up, years (IQR) | 4.0 (1.3–8.1) | - |
| Cortisol Secretion a | ||
| Yes | 18 (48.6) | - |
| No | 9 (24.3) | - |
| Mitosis Count b | ||
| ≥20/HPF | 7 (18.9) | - |
| <20/HPF | 22 (59.5) | - |
| Ki67 c | ||
| ≥20% | 11 (29.7) | - |
| 10–19% | 4 (10.8) | - |
| <10% | 7 (18.9) | - |
Values are expressed as mean ± standard deviation, number (%), or median (IQR). a The available number was 27 because of missing values; b The available number was 29 because of missing values; c The available number was 22 because of missing values. ACC—adrenal cortical carcinoma; ENSAT—European Network for the Study of Adrenal Tumor; HPF—high power field; IQR—interquartile range.